Table 2 Pathological and clinical responses
Modified intention-to-treat population | Per-protocol population | |
|---|---|---|
(n = 79) | (n = 70) | |
Total pathological complete response | 24 (30%) | 22 (31%) |
Pathological complete response in breast | 28 (35%) | 26 (37%) |
Residual cancer burden score | ||
0 | 24 (30%) | 22 (31%) |
I | 20 (25%) | 20 (29%) |
II | 21 (27%) | 18 (26%) |
III | 14 (18%) | 10 (14%) |
Complete response | 4 (5%) | 4 (6%) |
Partial response | 65 (82%) | 59 (84%) |
Stable disease | 10 (13%) | 7 (10%) |
